ScholarGate
어시스턴트

방법 비교

선택한 방법을 나란히 검토하세요. 서로 다른 행은 강조 표시됩니다.

EORTC QLQ-C15-PAL: 완화 암 치료에서의 삶의 질×EORTC QLQ-LC13: 폐암에서의 삶의 질×
분야종양학종양학
계열Process / pipelineProcess / pipeline
기원 연도20061994
창시자Groenvold, M., et al. (EORTC Quality of Life Group)Bergman, B., et al. (EORTC Quality of Life Group)
유형Self-report questionnaireSelf-report questionnaire
원전Groenvold, M., Petersen, M. A., Aaronson, N. K., Arraras, J. I., Blazeby, J. M., Bottomley, A., et al. (2006). The development of the EORTC QLQ-C15-PAL: a shortened quality-of-life questionnaire for cancer patients in palliative care. Eur J Cancer, 42(1), 55–64. DOI ↗Bergman, B., Aaronson, N. K., Ahmedzai, S., Kaasa, S., & Sullivan, M. (1994). The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer, 30A(5), 635–642. DOI ↗
별칭QLQ-C15-PALQLQ-LC13
관련55
요약The EORTC QLQ-C15-PAL is a 15-item quality-of-life instrument specifically designed for advanced cancer patients receiving palliative care. Developed by Groenvold et al. in 2006, it is a shortened version of the QLQ-C30, retaining core QoL domains while reducing respondent burden—critical in palliative settings where fatigue and functional impairment limit questionnaire completion. It measures physical, emotional, and functional well-being alongside key palliative symptoms.The EORTC QLQ-LC13 is a 13-item lung-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire. Developed and validated by Bergman et al. in 1994, it measures lung-specific symptoms (dyspnea, cough, hemoptysis, chest pain) and treatment toxicities (sore mouth, dysphagia). It is the standard lung cancer-specific QoL instrument in European and international trials.
ScholarGate데이터셋
  1. v1
  2. 2 출처
  3. PUBLISHED
  1. v1
  2. 2 출처
  3. PUBLISHED

검색으로 이동 슬라이드 다운로드

ScholarGate방법 비교: EORTC QLQ-C15-PAL · EORTC QLQ-LC13. 2026-06-19에 다음에서 검색함: https://scholargate.app/ko/compare